Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GeNeuro SA
With
Les Laboratoires Servier
Worldwide Clinical Trials
Institut de Recherches Internationales Servier
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must have completed Period 2 of study GNC-003 and must meet all eligibility criteria for the GNC-004 study
Patients (male or female with reproductive potential) must agree to use highly effective methods of birth control
Provision of written informed consent to participate prior to any trial procedure as shown by signature on the subject consent form.
You may not be if
Patients not having completed the study GNC-003
Pregnancy
The emergence of any disease diagnosis during the course of study GNC-003 that is not MS and could better explain the patient's neurological signs and symptoms
Clareo Health | Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis
